Literature DB >> 6206582

Substernal gastric bypass of the excluded esophagus--results of an ill-advised operation.

M B Orringer.   

Abstract

Substernal gastric bypass of the excluded thoracic esophagus for palliation of esophageal carcinoma was proposed as a method of providing maximum patient comfort with minimum morbidity. Our results with this operation in 37 patients are reviewed and indicate that the procedure carries unacceptable complication and mortality rates. Among our patients, there have been nine (24%) hospital deaths, seven (19%) anastomotic leaks, and six (17%) disruptions of the divided distal thoracic esophagus. Major postoperative complications have occurred in 59% of these patients. Only 15 (54%) of the 28 survivors were discharged swallowing within 3 weeks of operation, and 10 (36%) required hospitalization for 1 month or longer after operation. The average survival time in those leaving the hospital alive has been only 5.9 months. Only seven patients (25% of the survivors) have achieved good palliation with the bypass procedure. It is concluded that substernal gastric bypass of the excluded thoracic esophagus is too much of an operation for patients with unresectable tumors who have a life expectancy of only several months.

Entities:  

Mesh:

Year:  1984        PMID: 6206582

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  8 in total

1.  Motor function in the excluded esophagus and its implications in the management of patients with unresectable carcinoma of the esophagus.

Authors:  A C Duranceau; E R Lafontaine; S C Archambault; G G Jamieson
Journal:  Ann Surg       Date:  1987-12       Impact factor: 12.969

Review 2.  Light at the end of the tunnel? Palliation for oesophageal carcinoma.

Authors:  J Cox; J R Bennett
Journal:  Gut       Date:  1987-07       Impact factor: 23.059

3.  Anastomotic leakage after resection and bypass for esophageal cancer: lessons learned from the past.

Authors:  T Lorentz; M Fok; J Wong
Journal:  World J Surg       Date:  1989 Jul-Aug       Impact factor: 3.352

4.  Endoscopic Nd-YAG laser therapy as palliative treatment for esophageal and cardial cancer. Parameters affecting long-term outcome.

Authors:  S Naveau; A Chiesa; T Poynard; J C Chaput
Journal:  Dig Dis Sci       Date:  1990-03       Impact factor: 3.199

Review 5.  Surgical management of carcinoma of the esophagus.

Authors:  J C Harvey; E J Beattie
Journal:  Bull N Y Acad Med       Date:  1993 Jan-Feb

Review 6.  Comparison of different treatments for unresectable esophageal cancer.

Authors:  C E Reed
Journal:  World J Surg       Date:  1995 Nov-Dec       Impact factor: 3.352

7.  Complications after ultrasonic lung parenchyma biopsy: a strong note for caution.

Authors:  T F Molnar; I Benko; Z Szanto; A Nagy; O P Horvath
Journal:  Surg Endosc       Date:  2008-03       Impact factor: 4.584

8.  Comparative study of self-expanding metal stent and intraluminal radioactive stent for inoperable esophageal squamous cell carcinoma.

Authors:  Dong Tian; Hongying Wen; Maoyong Fu
Journal:  World J Surg Oncol       Date:  2016-01-22       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.